CNS Infections pp 139-161 | Cite as

CNS Tuberculosis and Other Mycobacterial Infections

  • Juan Carlos García-MoncóEmail author
  • Aida Rodriguez-Sainz


Tuberculous meningitis is the most severe form of tuberculous infection (Mycobacterium tuberculosis) and presents as a subacute syndrome with lymphocytic pleocytosis and low glucose in the cerebrospinal fluid (CSF) and meningeal enhancement of the basal cisterns and hydrocephalus on neuroimaging.

Diagnosis is challenging, since CSF cultures take long and are positive in less than two-thirds of patients. Empirical therapy is thus often employed. Mortality rate of this infection remains at approximately 25 % of the patients.

Parenchymal involvement (tuberculomas and spinal cord damage) may also appear.

Nontuberculous mycobacteria affect AIDS patients. M. avium complex is most frequently implicated. CNS infection is rare and occurs with disseminated disease. Diagnosis is made by culture of involved tissues, and therapy requires a prolonged, multidrug regimen.


Tuberculosis Mycobacterium tuberculosis Tuberculoma Tuberculous abscess Tuberculous meningitis 


  1. 1.
    Kaufmann SH. Robert Koch, the Nobel Prize, and the ongoing threat of tuberculosis. N Engl J Med. 2005;353(23):2423–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Rieder HL, Snider Jr DE, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis. 1990;141(2):347–51.PubMedCrossRefGoogle Scholar
  3. 3.
    Gupta RK, Kohli A, Gaur V, et al. MRI of the brain in patients with miliary pulmonary tuberculosis without symptoms or signs of central nervous system involvement. Neuroradiology. 1997;39(10):699–704.PubMedCrossRefGoogle Scholar
  4. 4.
    Garcia-Monco JC. Central nervous system tuberculosis. Neurol Clin. 1999;17(4):737–59.PubMedCrossRefGoogle Scholar
  5. 5.
    Illingworth RS. The early diagnosis of tuberculous meningitis. Br Med J. 1950;1:479–81.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Council BMR. Streptomycin treatment of tuberculous meningitis. Lancet. 1948;1:582–96.Google Scholar
  7. 7.
    Verdon R, Chevret S, Laissy JP, Wolff M. Tuberculous meningitis in adults: review of 48 cases [see comments]. Clin Infect Dis. 1996;22(6):982–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Pinto Jr VL, Lima MA, Boia MN. Persistent neutrophilic meningitis. J Neurol Neurosurg Psychiatry. 2009;80(6):697–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Sanchez-Portocarrero J, Perez-Cecilia E, Jimenez-Escrig A, et al. Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol. 1996;53(7):671–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Garcia-Monco JC, Ferreira E, Gomez-Beldarrain M. The therapeutic paradox in the diagnosis of tuberculous meningitis. Neurology. 2005;65(12):1991–2.PubMedCrossRefGoogle Scholar
  11. 11.
    Ogawa SK, Smith MA, Brennessel DJ, Lowy FD. Tuberculous meningitis in an urban medical center. Medicine (Baltimore). 1987;66(4):317–26.PubMedCrossRefGoogle Scholar
  12. 12.
    Barret-Connor E. Tuberculous meningitis in adults. South Med J. 1967;60:1060–7.CrossRefGoogle Scholar
  13. 13.
    Thwaites GE, Chau TT, Stepniewska K, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 2002;360(9342):1287–92.PubMedCrossRefGoogle Scholar
  14. 14.
    Moghtaderi A, Alavi-Naini R, Izadi S, Cuevas LE. Diagnostic risk factors to differentiate tuberculous and acute bacterial meningitis. Scand J Infect Dis. 2009;41(3):188–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Chen P, Shi M, Feng GD, et al. A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol. 2012;50(4):1166–70.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Thwaites GE. Advances in the diagnosis and treatment of tuberculous meningitis. Curr Opin Neurol. 2013;26(3):295–300.PubMedCrossRefGoogle Scholar
  17. 17.
    Metcalfe JZ, Everett CK, Steingart KR, et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis. 2011;204 Suppl 4:S1120–9.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Watterson SA, Drobniewski FA. Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol. 2000;53(10):727–32.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Ho J, Marais BJ, Gilbert GL, Ralph AP. Diagnosing tuberculous meningitis – have we made any progress? Trop Med Int Health. 2013;18(6):783–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Malan C, Donald PR, Golden M, Taljaard JJ. Adenosine deaminase levels in cerebrospinal fluid in the diagnosis of tuberculous meningitis. J Trop Med Hyg. 1984;87(1):33–40.PubMedGoogle Scholar
  21. 21.
    Mishra OP, Loiwal V, Ali Z, et al. Cerebrospinal fluid adenosine deaminase activity for the diagnosis of tuberculous meningitis in children. J Trop Pediatr. 1996;42(3):129–32.PubMedCrossRefGoogle Scholar
  22. 22.
    Pettersson T, Klockars M, Weber TH, Somer H. Diagnostic value of cerebrospinal fluid adenosine deaminase determination [see comments]. Scand J Infect Dis. 1991;23(1):97–100.PubMedCrossRefGoogle Scholar
  23. 23.
    Ribera E, Martinez-Vazquez JM, Ocana I, et al. Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults. J Infect Dis. 1987;155(4):603–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Garcia-Monco C, Berciano J. Sarcoid meningitis, high adenosine deaminase levels in CSF and results of cranial irradiation [letter]. J Neurol Neurosurg Psychiatry. 1988;51(12):1594–6.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Tuon FF, Higashino HR, Lopes MI, et al. Adenosine deaminase and tuberculous meningitis – a systematic review with meta-analysis. Scand J Infect Dis. 2010;42(3):198–207.PubMedCrossRefGoogle Scholar
  26. 26.
    Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [see comments]. Nature. 1998;393(6685):537–44.PubMedCrossRefGoogle Scholar
  27. 27.
    Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003;3(10):633–43.PubMedCrossRefGoogle Scholar
  28. 28.
    Haldar S, Sankhyan N, Sharma N, et al. Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children. PLoS One. 2012;7(9):e44630.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Ozates M, Kemaloglu S, Gurkan F, et al. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol. 2000;41(1):13–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus [see comments]. N Engl J Med. 1992;326(10):668–72.PubMedCrossRefGoogle Scholar
  31. 31.
    Belorgey L, Lalani I, Zakaria A. Ischemic stroke in the setting of tuberculous meningitis. J Neuroimaging. 2006;16(4):364–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Alarcon F, Escalante L, Perez Y, et al. Tuberculous meningitis. Short course of chemotherapy [published erratum appears in Arch Neurol 1991 Sep;48(9):920]. Arch Neurol. 1990;47(12):1313–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Leiguarda R, Berthier M, Starkstein S, et al. Ischemic infarction in 25 children with tuberculous meningitis. Stroke. 1988;19(2):200–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Daif AK, al Rajeh S, Ogunniyi A, et al. Syringomyelia developing as an acute complication of tuberculous meningitis. Can J Neurol Sci. 1997;24(1):73–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Bass Jr JB, Farer LS, Hopewell PC, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention [see comments]. Am J Respir Crit Care Med. 1994;149(5):1359–74.PubMedCrossRefGoogle Scholar
  36. 36.
    Horsburgh Jr CR, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis. 2000;31(3):633–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167–87.PubMedCrossRefGoogle Scholar
  38. 38.
    Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med. 2001;345(3):189–200.PubMedCrossRefGoogle Scholar
  39. 39.
    van Loenhout-Rooyackers JH, Keyser A, Laheij RJ, et al. Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis. 2001;5(11):1028–35.PubMedGoogle Scholar
  40. 40.
    Dutt AK, Moers D, Stead WW. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years’ experience. Ann Intern Med. 1986;104(1):7–12.PubMedCrossRefGoogle Scholar
  41. 41.
    Donald PR, Schoeman JF, Van Zyl LE, et al. Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis. 1998;2(9):704–11.PubMedGoogle Scholar
  42. 42.
    Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013;13(1):27–35.PubMedCrossRefGoogle Scholar
  43. 43.
    Heemskerk D, Day J, Chau TT, et al. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial. Trials. 2011;12:25.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis. 1997;25(4):872–87.PubMedCrossRefGoogle Scholar
  45. 45.
    Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 1997;99(2):226–31.PubMedCrossRefGoogle Scholar
  46. 46.
    Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741–51.PubMedCrossRefGoogle Scholar
  47. 47.
    Fortun J, Gomez-Mampaso E, Navas E, et al. Tuberculous meningitis caused by resistant microorganisms. Therapeutic failure in 2 patients with HIV infection and disseminated tuberculosis (see comments). Enferm Infecc Microbiol Clin. 1994;12(3):150–3.PubMedGoogle Scholar
  48. 48.
    Horn DL, Hewlett Jr D, Peterson S, et al. RISE-resistant tuberculous meningitis in AIDS patient [letter]. Lancet. 1993;341(8838):177–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Steiner P, Rao M, Victoria MS, et al. A continuing study of primary drug-resistant tuberculosis among children observed at the Kings County Hospital Medical Center between the years 1961 and 1980. Am Rev Respir Dis. 1983;128(3):425–8.PubMedGoogle Scholar
  50. 50.
    Berning SE, Cherry TA, Iseman MD. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis. 2001;32(4):643–6.PubMedCrossRefGoogle Scholar
  51. 51.
    WHO. WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization (WHO); 2008.Google Scholar
  52. 52.
    Sheu JJ, Yuan RY, Yang CC. Predictors for outcome and treatment delay in patients with tuberculous meningitis. Am J Med Sci. 2009;338(2):134–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Kalita J, Misra UK, Ranjan P. Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. Eur J Neurol. 2007;14(1):33–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Dastur DK, Lalitha VS, Prabhakar V. Pathological analysis of intracranial space-occupying lesions in 1000 cases including children. 1. Age, sex and pattern; and the tuberculomas. J Neurol Sci. 1968;6(3):575–92.PubMedCrossRefGoogle Scholar
  55. 55.
    Jinkins JR. Computed tomography of intracranial tuberculosis. Neuroradiology. 1991;33(2):126–35.PubMedCrossRefGoogle Scholar
  56. 56.
    Man H, Sellier P, Boukobza M, et al. Central nervous system tuberculomas in 23 patients. Scand J Infect Dis. 2010;42(6–7):450–4.PubMedCrossRefGoogle Scholar
  57. 57.
    Mayers MM, Kaufman DM, Miller MH. Recent cases of intracranial tuberculomas. Neurology. 1978;28(3):256–60.PubMedCrossRefGoogle Scholar
  58. 58.
    Whiteman ML. Neuroimaging of central nervous system tuberculosis in HIV-infected patients. Neuroimaging Clin N Am. 1997;7(2):199–214.PubMedGoogle Scholar
  59. 59.
    Kong A, Koukourou A, Boyd M, Crowe G. Metastatic adenocarcinoma mimicking ‘target sign’ of cerebral tuberculosis. J Clin Neurosci. 2006;13(9):955–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Gupta RK, Jena A, Singh AK, et al. Role of magnetic resonance (MR) in the diagnosis and management of intracranial tuberculomas. Clin Radiol. 1990;41(2):120–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Basoglu OK, Savas R, Kitis O. Conventional and diffusion-weighted MR imaging of intracranial tuberculomas. A case report. Acta Radiol. 2002;43(6):560–2.PubMedCrossRefGoogle Scholar
  62. 62.
    Pui MH, Ahmad MN. Magnetization transfer imaging diagnosis of intracranial tuberculomas. Neuroradiology. 2002;44(3):210–5.PubMedCrossRefGoogle Scholar
  63. 63.
    DeAngelis LM. Intracranial tuberculoma: case report and review of the literature. Neurology. 1981;31(9):1133–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Garcia-Monco JC, Gomez Beldarrain M, Fernandez Canton G, et al. Resolution of a brainstem abscess through antituberculous therapy [see comments]. Neurology. 1997;49(1):265–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Arseni C. Two hundred and one cases of intracranial tuberculoma treated surgically. J Neurol Neurosurg Psychiatry. 1958;21:308–11.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis. 1994;19(6):1092–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Cheng VC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21(11):803–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Hejazi N, Hassler W. Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Acta Neurochir (Wien). 1997;139(3):194–202.PubMedCrossRefGoogle Scholar
  69. 69.
    Tyson G, Newman P, Strachan WE. Tuberculous brain abscess. Surg Neurol. 1978;10(5):323–5.PubMedGoogle Scholar
  70. 70.
    Kumar R, Pandey CK, Bose N, Sahay S. Tuberculous brain abscess: clinical presentation, pathophysiology and treatment (in children). Childs Nerv Syst. 2002;18(3–4):118–23.PubMedCrossRefGoogle Scholar
  71. 71.
    Sermet-Gaudelus I, Stambouli F, Abadie V, et al. Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment. Eur J Clin Microbiol Infect Dis. 1999;18(10):726–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Kocen RS, Parsons M. Neurological complications of tuberculosis: some unusual manifestations. Q J Med. 1970;39(153):17–30.PubMedGoogle Scholar
  73. 73.
    Dastur D, Wadia NH. Spinal meningitides with radiculo-myelopathy. 2. Pathology and pathogenesis. J Neurol Sci. 1969;8(2):261–97.PubMedCrossRefGoogle Scholar
  74. 74.
    Gupta RK, Gupta S, Kumar S, et al. MRI in intraspinal tuberculosis. Neuroradiology. 1994;36(1):39–43.PubMedCrossRefGoogle Scholar
  75. 75.
    de La Blanchardiere A, Stern JB, Molina JM, et al. Spinal tuberculous arachnoiditis. Presse Med. 1996;25(29):1333–5.Google Scholar
  76. 76.
    Lu M. Imaging diagnosis of spinal intramedullary tuberculoma: case reports and literature review. J Spinal Cord Med. 2010;33(2):159–62.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Hanci M, Sarioglu AC, Uzan M, et al. Intramedullary tuberculous abscess: a case report. Spine. 1996;21(6):766–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Modic MT, Feiglin DH, Piraino DW, et al. Vertebral osteomyelitis: assessment using MR. Radiology. 1985;157(1):157–66.PubMedGoogle Scholar
  79. 79.
    Thwaites GE, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis. 2005;192(12):2134–41.PubMedCrossRefGoogle Scholar
  80. 80.
    Whiteman M, Espinoza L, Post MJ, et al. Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings. AJNR Am J Neuroradiol. 1995;16(6):1319–27.PubMedGoogle Scholar
  81. 81.
    Wallace RJ. Antimycobacterial agents. In: Mandell GI, Bennet JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill-Livingstone; 2000. p. 436–48.Google Scholar
  82. 82.
    Gordon SM, Horsburgh Jr CR, Peloquin CA, et al. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Infect Dis. 1993;168(6):1559–62.PubMedCrossRefGoogle Scholar
  83. 83.
    Pozniak AL, MacLeod GA, Mahari M, et al. The influence of HIV status on single and multiple drug reactions to antituberculous therapy in Africa. Aids. 1992;6(8):809–14.PubMedCrossRefGoogle Scholar
  84. 84.
    Rao GP, Nadh BR, Hemaratnan A, et al. Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. J Neurosurg. 1995;83:359–62.PubMedCrossRefGoogle Scholar
  85. 85.
    Anonymous. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 1998;47(RR-20):1–58.Google Scholar
  86. 86.
    Marais S, Scholtz P, Pepper DJ, et al. Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome. Int J Tuberc Lung Dis. 2010;14(2):188–96.PubMedGoogle Scholar
  87. 87.
    Brown BA, Wallace Jr RJ. Infections due to nontuberculous mycobacteria. In: Mandell GI, Bennet JE, Dolin R, editors. Principles and practice of infectious disease. Philadelphia: Churchill-Livingstone; 2000. p. 2630–6.Google Scholar
  88. 88.
    Cook VJ, Turenne CY, Wolfe J, et al. Conventional methods versus 16S ribosomal DNA sequencing for identification of nontuberculous mycobacteria: cost analysis. J Clin Microbiol. 2003;41(3):1010–5.PubMedCentralPubMedCrossRefGoogle Scholar
  89. 89.
    Brown-Elliott BA, Griffith DE, Wallace Jr RJ. Diagnosis of nontuberculous mycobacterial infections. Clin Lab Med. 2002;22(4):911–25, vi.PubMedCrossRefGoogle Scholar
  90. 90.
    Flor A, Capdevila JA, Martin N, et al. Nontuberculous mycobacterial meningitis: report of two cases and review [see comments]. Clin Infect Dis. 1996;23(6):1266–73.PubMedCrossRefGoogle Scholar
  91. 91.
    Jacob CN, Henein SS, Heurich AE, Kamholz S. Nontuberculous mycobacterial infection of the central nervous system in patients with AIDS. South Med J. 1993;86(6):638–40.PubMedCrossRefGoogle Scholar
  92. 92.
    Weiss IK, Krogstad PA, Botero C, et al. Fatal Mycobacterium avium meningitis after mis-identification of M tuberculosis. Lancet. 1995;345(8955):991–2.PubMedCrossRefGoogle Scholar
  93. 93.
    Berman SM, Kim RC, Haghighat D, et al. Mycobacterium genavense infection presenting as a solitary brain mass in a patient with AIDS: case report and review. Clin Infect Dis. 1994;19(6):1152–4.PubMedCrossRefGoogle Scholar
  94. 94.
    Duong M, Piroth L, Chavanet P, et al. A case of rhombencephalitis with isolation of cytomegalovirus and Mycobacterium avium complex in a woman with AIDS [letter]. Aids. 1994;8(9):1356–7.PubMedCrossRefGoogle Scholar
  95. 95.
    Uldry PA, Bogousslavsky J, Regli F, et al. Chronic Mycobacterium avium complex infection of the central nervous system in a nonimmunosuppressed woman. Eur Neurol. 1992;32(5):285–8.PubMedCrossRefGoogle Scholar
  96. 96.
    Gyure KA, Prayson RA, Estes ML, Hall GS. Symptomatic Mycobacterium avium complex infection of the central nervous system. A case report and review of the literature [see comments]. Arch Pathol Lab Med. 1995;119(9):836–9.PubMedGoogle Scholar
  97. 97.
    Landgraf IM, Palaci M, Vieira MF, et al. Bacterial agents isolated from cerebrospinal fluid of patients with acquired immunodeficiency syndrome (AIDS) and neurological complications. Rev Inst Med Trop Sao Paulo. 1994;36(6):491–6.PubMedCrossRefGoogle Scholar
  98. 98.
    Hadad DJ, Petry TC, Maresca AF, et al. Mycobacterium avium complex (MAC): an unusual potential pathogen in cerebrospinal fluid of AIDS patients. Rev Inst Med Trop Sao Paulo. 1995;37(2):93–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Norton GR, Sweeney J, Marriott D, et al. Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection [see comments]. J Neurol Neurosurg Psychiatry. 1996;61(6):606–9.PubMedCentralPubMedCrossRefGoogle Scholar
  100. 100.
    el-Zaatari FA, Graham DY, Samuelsson K, Engstrand L. Detection of Mycobacterium avium complex in cerebrospinal fluid of a sarcoid patient by specific polymerase chain reaction assays. Scand J Infect Dis. 1997;29(2):202–4.PubMedCrossRefGoogle Scholar
  101. 101.
    Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Thoracic Society Statement. Am J Respir Crit Care Med. 1997;156(2 Pt 2):S1–25.Google Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Juan Carlos García-Moncó
    • 1
    Email author
  • Aida Rodriguez-Sainz
    • 1
  1. 1.Department of NeurologyHospital de Galdakao-UsansoloGaldakao, VizcayaSpain

Personalised recommendations